Problem 7
Question
Write a balanced equation for the hydrolysis of cGMP, catalyzed by cGMP phosphodiesterase. Would you expect an inhibitor of this enzyme to potentiate or antagonize the action of Viagra? Explain.
Step-by-Step Solution
Verified Answer
The hydrolysis of cGMP to GMP is catalyzed by cGMP phosphodiesterase. An inhibitor would potentiate Viagra's action by increasing cGMP levels, enhancing its effect.
1Step 1: Understand the reaction
cGMP or cyclic guanosine monophosphate is a cyclic nucleotide. Its hydrolysis by cGMP phosphodiesterase results in the breaking of the cyclic bond to form GMP or guanosine monophosphate. The balanced chemical reaction is: \[ \text{cGMP} + \text{H}_2\text{O} \rightarrow \text{GMP} \] Catalyzed by the enzyme cGMP phosphodiesterase.
2Step 2: Relate enzyme inhibition with Viagra's action
Viagra (sildenafil) works by blocking cGMP phosphodiesterase, specifically PDE5, leading to an increase in cGMP levels. Increased cGMP causes relaxation of smooth muscles and blood vessel dilation, facilitating erection. Therefore, an inhibitor of this enzyme enhances Viagra's action by potentiating the effect of increased cGMP.
Key Concepts
cGMPEnzyme InhibitionViagra Mechanism
cGMP
Cyclic guanosine monophosphate, commonly referred to as cGMP, is a vital molecule involved in numerous biochemical processes. This cyclic nucleotide serves as a secondary messenger that translates external signals into appropriate cellular responses. For instance, cGMP plays a significant role in regulating blood flow and smooth muscle relaxation.
At a molecular level, cGMP is formed from GTP (guanosine triphosphate) by the action of the enzyme guanylate cyclase. Once synthesized, it can go on to activate a cascade of intracellular events.
Understanding the behavior and pathways involving cGMP is crucial as improper regulation can lead to various health conditions. A key example includes its role in cardiovascular diseases and erectile dysfunction, where it's exploited therapeutically to regulate blood circulation effectively.
At a molecular level, cGMP is formed from GTP (guanosine triphosphate) by the action of the enzyme guanylate cyclase. Once synthesized, it can go on to activate a cascade of intracellular events.
- cGMP interacts with protein kinases to modify other proteins.
- It also influences ion channels and phosphodiesterases to control physiological processes.
Understanding the behavior and pathways involving cGMP is crucial as improper regulation can lead to various health conditions. A key example includes its role in cardiovascular diseases and erectile dysfunction, where it's exploited therapeutically to regulate blood circulation effectively.
Enzyme Inhibition
Enzyme inhibition is a regulatory mechanism where the activity of an enzyme is decreased or completely halted. This can occur through various types of inhibitors that alter enzyme action.
There are generally two large categories of inhibition:
Enzyme inhibitors have practical uses in medicine. For instance, by inhibiting specific enzymes in the body, it is possible to manage disease symptoms or slow disease progression.
When we look at the hydrolysis of cGMP, its breakdown to GMP is enacted by cGMP phosphodiesterase. Therefore, an inhibitor of this enzyme would prevent this conversion, resulting in elevated levels of cGMP. This is particularly beneficial in therapeutic settings, such as with the use of Viagra, where potentiation of cGMP levels is sought.
There are generally two large categories of inhibition:
- **Competitive Inhibition**: This occurs when an inhibitor competes with the substrate for binding at the enzyme's active site.
- **Non-Competitive Inhibition**: Here, the inhibitor binds to a different part of the enzyme, changing its shape and reducing its effectiveness.
Enzyme inhibitors have practical uses in medicine. For instance, by inhibiting specific enzymes in the body, it is possible to manage disease symptoms or slow disease progression.
When we look at the hydrolysis of cGMP, its breakdown to GMP is enacted by cGMP phosphodiesterase. Therefore, an inhibitor of this enzyme would prevent this conversion, resulting in elevated levels of cGMP. This is particularly beneficial in therapeutic settings, such as with the use of Viagra, where potentiation of cGMP levels is sought.
Viagra Mechanism
Viagra, known generically as sildenafil, is a well-known medication used primarily to treat erectile dysfunction. Its mechanism hinges on the strategic inhibition of an enzyme known as phosphodiesterase type 5 (PDE5).
PDE5's role in the body is to degrade cGMP, which can lead to reduced blood flow in certain areas. By selectively inhibiting PDE5, Viagra prevents the breakdown of cGMP, resulting in its accumulation.
The action of Viagra is not just about supporting physiological function but also ensuring the process is well-regulated. Importantly, Viagra does not cause an erection on its own; sexual arousal is an essential component for the drug to exert its effects. As such, inhibitors like Viagra are revolutionary in managing erectile dysfunction and exemplify the significant potential of enzyme inhibition in therapeutic applications.
PDE5's role in the body is to degrade cGMP, which can lead to reduced blood flow in certain areas. By selectively inhibiting PDE5, Viagra prevents the breakdown of cGMP, resulting in its accumulation.
- Increased cGMP levels promote the dilation of blood vessels.
- This enhances blood flow, particularly in the penile tissue, facilitating erection in response to sexual stimulation.
The action of Viagra is not just about supporting physiological function but also ensuring the process is well-regulated. Importantly, Viagra does not cause an erection on its own; sexual arousal is an essential component for the drug to exert its effects. As such, inhibitors like Viagra are revolutionary in managing erectile dysfunction and exemplify the significant potential of enzyme inhibition in therapeutic applications.
Other exercises in this chapter
Problem 4
Signaling molecules interact with cells through specific macromolecular receptors. For each of the four receptors identified below, list all characteristics, by
View solution Problem 5
Upon activation by a receptor, a G protein exchanges bound GDP for GTP, rather than phosphorylating GDP that is already bound. Similarly, the \(\alpha\) subunit
View solution Problem 9
Suppose that you measured binding to the isolated EGF receptor of EGF at various concentrations. Would you expect the binding curve to be hyperbolic? Explain yo
View solution Problem 10
Describe two features of insulin signaling that affect glucose utilization. A \(\beta\)-adrenergic response can be modulated through the actions of a receptor k
View solution